Assay-related differences in SuPAR levels: implications for measurement and data interpretation
Alexi Vasbinder(University of Washington), Salim S. Hayek(Rush University Medical Center), Jochen Reiser(The University of Texas Medical Branch at Galveston), Alex P. Reiner(Brigham and Women's Hospital), Arshed A. Quyyumi(Emory University), Gunnar Engström(Lund University), Yan Gao(The University of Texas Health Science Center at Houston), Laura Marie Raffield(University of North Carolina at Chapel Hill)
Cited by 15
Related Papers
SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe
|European Heart Journal|2021|1.7k
World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions
|The Lancet Global Health|2019|1.2k
Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US
|JAMA Internal Medicine|2020|1k
Genome-wide association and Mendelian randomisation analysis provide insights into the pathogenesis of heart failure
|Nature Communications|2020|924
Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis
|Nature Medicine|2011|834